At this point, in deciding how hard to try to avoid Omicron, you have to weigh (a) the extra immunity you might get against a worse variant in the future from getting Omicron against (b) the danger of dying, serious damage or getting Long Covid from Omicron. The lessening of the Paxlovid shortage reduces the expected cost of getting Omicron. The link on the title to this post is to a Bloomberg article about the lessening of the Paxlovid shortage.